Tuberculosis — metabolism and respiration in the absence of growth
The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Human tuberculosis is a complex disease caused by bacterial populations that are located in discrete lesions (microenvironments) in a single host. Some of these microenvironments are conducive to replication, whereas others restrict bacterial growth without necessarily sterilizing the infecting microorganisms. The physical and biochemical milieu in these lesions is poorly defined. None of the existing animal models for tuberculosis (except perhaps non-human primates) reproduce the diversity of disease progression that is seen in humans. Nonetheless, transcriptomics and studies using bacterial mutants have led to testable hypotheses about metabolic functions that are essential for viability in the absence of replication. A complete picture of bacterial metabolism must balance reducing equivalents while maintaining an energized membrane and basic cellular processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“M. tuberculosis harbours genes for a cytochrome c pathway consisting of a menaquinol-cytochrome c oxidoreductase termed the bc1 complex (encoded by the qcrCAB operon, complex III) and an aa3-type cytochrome c oxidase (encoded by the genes ctaBCDE, complex IV) belonging to the heme-copper respiratory oxidase family (69–71) (Table 1).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [69]
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · cited 1×
“tuberculosis encodes four glucose-6-phosphate dehydrogenases — two of which require NADPH as the electron donor ( zwf1 , zwf2 ), whereas fgd1 and fgd2 encode F 420 -requiring dehydrogenase”
BackgroundSelf-citationExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“However, tumour cells are able to adjust their metabolism to adapt to anaerobic condition”
BackgroundThe Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469 · cited 1×
“3 ), whereas higher concentrations might reach other sensitive intracellular target”
BackgroundTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180 · cited 1×
“tuberculosis during the chronic stage of the disease in mice is largely dependent on production of nitric oxide and other REACTIVE NITROGEN INTERMEDIATES (RNI), with decreased production of RNIs leading to reactivation of diseas”
BackgroundWayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Research works printed but not linked: 4
- Jagirdar, J. & Zagzag, D. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 323–344 (Lippincott Williams & Wilkins, Philadelphia, 2004). A good current and historical overview of the pathology of different forms of tuberculosis in humans.
- Daley, C. L. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 85–99 (Lippincott Williams & Wilkins, Philadelphia, 2004).
- Condos, R. & Rom, W. N. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 285–299 (Lippincott Williams & Wilkins, Philadelphia, 2004).
- Garay, S. M. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 345–394 (Lippincott Williams & Wilkins, Philadelphia, 2004). A review of the clinical aspects of pulmonary tuberculosis with well-documented case studies of reactivation disease.
Cited by
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
“The potential therapeutic benefits of such agents arises from the fact that the membrane is vital to both active and metabolically inactive pathogens, and quiescent bacteria, like all living cells, require some form of cellular energy and redox homeostasis to maintain cell viability, even in the absence of growt”
Muñoz-Elías, E. J., & McKinney, J. D. (2005) · Nature Medicine · doi:10.1038/nm1252 · Cited by 756
“Elucidation of the metabolic pathways required for growth and persistence of Mycobacterium tuberculosis in the mammalian lung could point to new avenues of intervention against this recalcitrant pathoge”
BackgroundPA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
Self-citation
Metadata
- Authors
- Boshoff, H. I. M., & Barry, C. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Boshoff, Helena I. M.
- Venue
- Nature Reviews Microbiology
- Published
- 2005-01
- Volume
- 3
- Issue
- 1
- Pages
- 70-80
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1973789730
- Cited by
- 448
- References
- 88
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 11 · 2023: 11 · 2022: 9 · 2021: 17 · 2020: 20 · 2019: 22 · 2018: 21 · 2017: 22 · 2016: 20 · 2015: 35 · 2014: 30 · 2013: 24 · 2012: 26
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI000783)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis, Mycobacterium tuberculosis, bacterial metabolism, respiration, non-replicating persistence, animal models of tuberculosis, transcriptomics, bacterial mutants, reducing equivalents, membrane potential, bacterial viability
- MeSH terms
- Adaptation, Physiological, Animals, Citric Acid Cycle, Gluconeogenesis, Humans, Mycobacterium tuberculosis, Oxidation-Reduction, Oxygen Consumption, Riboflavin, Tuberculosis, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.